LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS

The center for diagnostic, treatment, rehabilitation and social adaptation of patients with cystic fibrosis was established in pulmonology department of the children's clinical hospital № 3 of Novosibirsk in 1994. Since 1995 the database of the center has registered 23 patients. the center has...

Full description

Bibliographic Details
Main Authors: N.I. Romanenko, E.G. Kondiurina, I.V. Sultanova, A.A. L’vov, A.V. Likhanov
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2006-03-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/720
_version_ 1797697741989609472
author N.I. Romanenko
E.G. Kondiurina
I.V. Sultanova
A.A. L’vov
A.V. Likhanov
author_facet N.I. Romanenko
E.G. Kondiurina
I.V. Sultanova
A.A. L’vov
A.V. Likhanov
author_sort N.I. Romanenko
collection DOAJ
description The center for diagnostic, treatment, rehabilitation and social adaptation of patients with cystic fibrosis was established in pulmonology department of the children's clinical hospital № 3 of Novosibirsk in 1994. Since 1995 the database of the center has registered 23 patients. the center has carried out an open prospective study of clinical efficacy and safety of dornase alfa (pulmozyme, «F. hoffmannala roche ltd.», basel) in 10 patients with cystic fibrosis. The patients have received mucolytic therapy with dornase alfa for 2 years (2003–2005). They have been administered a daily inhalation of 2.5 ml of the solution (pulmozyme inhalation solution) containing 2.5 of dornaza alfa. The study has shown an improvement of pulmonary function and elevation of oxygen saturation. The number of respiratory infections have dropped by 33%, the administration of intravenous antibiotics has shortened by 25%, the nutrition status has trended towards improvement. regardless of it's high price, dornasa alfa has proven its' benefits in the treatment of cystic fibrosis in patients of any age and disease severity.Key words: dornase alfa, children, cystic fibrosis, treatment.
first_indexed 2024-03-12T03:44:26Z
format Article
id doaj.art-462035643cdc4b8dbfa2d86815d10c99
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T03:44:26Z
publishDate 2006-03-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-462035643cdc4b8dbfa2d86815d10c992023-09-03T12:58:10Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352006-03-01525658720LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSISN.I. Romanenko0E.G. Kondiurina1I.V. Sultanova2A.A. L’vov3A.V. Likhanov4Новосибирская государственная медицинская академияНовосибирская государственная медицинская академияНовосибирская государственная медицинская академияНовосибирская государственная медицинская академияНовосибирская государственная медицинская академияThe center for diagnostic, treatment, rehabilitation and social adaptation of patients with cystic fibrosis was established in pulmonology department of the children's clinical hospital № 3 of Novosibirsk in 1994. Since 1995 the database of the center has registered 23 patients. the center has carried out an open prospective study of clinical efficacy and safety of dornase alfa (pulmozyme, «F. hoffmannala roche ltd.», basel) in 10 patients with cystic fibrosis. The patients have received mucolytic therapy with dornase alfa for 2 years (2003–2005). They have been administered a daily inhalation of 2.5 ml of the solution (pulmozyme inhalation solution) containing 2.5 of dornaza alfa. The study has shown an improvement of pulmonary function and elevation of oxygen saturation. The number of respiratory infections have dropped by 33%, the administration of intravenous antibiotics has shortened by 25%, the nutrition status has trended towards improvement. regardless of it's high price, dornasa alfa has proven its' benefits in the treatment of cystic fibrosis in patients of any age and disease severity.Key words: dornase alfa, children, cystic fibrosis, treatment.https://vsp.spr-journal.ru/jour/article/view/720дорназа альфадетимуковисцидозлечение
spellingShingle N.I. Romanenko
E.G. Kondiurina
I.V. Sultanova
A.A. L’vov
A.V. Likhanov
LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
Вопросы современной педиатрии
дорназа альфа
дети
муковисцидоз
лечение
title LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
title_full LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
title_fullStr LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
title_full_unstemmed LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
title_short LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
title_sort long term mucolytic therapy with dornase alfa at novosibirsk center for diagnostics treatment rheabilitation and adaptation of children with cystic fibrosis
topic дорназа альфа
дети
муковисцидоз
лечение
url https://vsp.spr-journal.ru/jour/article/view/720
work_keys_str_mv AT niromanenko longtermmucolytictherapywithdornasealfaatnovosibirskcenterfordiagnosticstreatmentrheabilitationandadaptationofchildrenwithcysticfibrosis
AT egkondiurina longtermmucolytictherapywithdornasealfaatnovosibirskcenterfordiagnosticstreatmentrheabilitationandadaptationofchildrenwithcysticfibrosis
AT ivsultanova longtermmucolytictherapywithdornasealfaatnovosibirskcenterfordiagnosticstreatmentrheabilitationandadaptationofchildrenwithcysticfibrosis
AT aalvov longtermmucolytictherapywithdornasealfaatnovosibirskcenterfordiagnosticstreatmentrheabilitationandadaptationofchildrenwithcysticfibrosis
AT avlikhanov longtermmucolytictherapywithdornasealfaatnovosibirskcenterfordiagnosticstreatmentrheabilitationandadaptationofchildrenwithcysticfibrosis